CN105853911A - Prescription for treating cytomegalovirus infectious heptitis - Google Patents

Prescription for treating cytomegalovirus infectious heptitis Download PDF

Info

Publication number
CN105853911A
CN105853911A CN201610255404.4A CN201610255404A CN105853911A CN 105853911 A CN105853911 A CN 105853911A CN 201610255404 A CN201610255404 A CN 201610255404A CN 105853911 A CN105853911 A CN 105853911A
Authority
CN
China
Prior art keywords
parts
rhizoma
prescription
treating
radix
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201610255404.4A
Other languages
Chinese (zh)
Inventor
张全月
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN201610255404.4A priority Critical patent/CN105853911A/en
Publication of CN105853911A publication Critical patent/CN105853911A/en
Pending legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/88Liliopsida (monocotyledons)
    • A61K36/906Zingiberaceae (Ginger family)
    • A61K36/9066Curcuma, e.g. common turmeric, East Indian arrowroot or mango ginger
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/11Pteridophyta or Filicophyta (ferns)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/23Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
    • A61K36/233Bupleurum
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/28Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
    • A61K36/284Atractylodes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/34Campanulaceae (Bellflower family)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/36Caryophyllaceae (Pink family), e.g. babysbreath or soapwort
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/57Magnoliaceae (Magnolia family)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/63Oleaceae (Olive family), e.g. jasmine, lilac or ash tree
    • A61K36/634Forsythia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/70Polygonaceae (Buckwheat family), e.g. spineflower or dock
    • A61K36/704Polygonum, e.g. knotweed
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/71Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/74Rubiaceae (Madder family)
    • A61K36/748Oldenlandia or Hedyotis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/79Schisandraceae (Schisandra family)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/88Liliopsida (monocotyledons)
    • A61K36/884Alismataceae (Water-plantain family)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/88Liliopsida (monocotyledons)
    • A61K36/896Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

The invention discloses a prescription for treating cytomegalovirus infectious hepatitis. The prescription for treating the cytomegalovirus infectious hepatitis is prepared from the following raw-material components in proportions by weight: 3 parts of aromatic turmeric root-tuber, 2 parts of fructus schisandrae chinensis, 1 part of radix bupleurum Chinese, 1 part of fructus forsythiae, 1 part of cortex moutan, 1 part of herba ardisiae japonicae, 1 part of rhizoma paridis chinensis, 1 part of root of rhizoma polygoni cuspidate, 2 parts of herba lobeliae chinensis, 2 parts of herba hedyotidis diffusae, 1 part of rhizoma atractylodis macrocephalae preparata, 1 part of rhizoma alismatis and 2 parts of radix pseudostellariae. The raw-material components are decocted with water for half an hour, and filtrate is orally taken; a dose is taken every day, and is orally taken twice or thrice; the filtrate is orally taken for 1 month to 3 months.

Description

A kind of prescription treating cytomegalovirus infectivity hepatitis
Technical field
The present invention relates to a kind of Chinese medicine, be specifically related to a kind of prescription treating cytomegalovirus infectivity hepatitis.
Background technology
Viral hepatitis serious threat human health, the commonly encountered diseases of Yi Shi China and frequently-occurring disease.Chronic hepatitis can Progress to hepatic fibrosis, and develop into liver cirrhosis, End-stage liver disease etc..In each Clinical types hepatitis, Simple infection rate is 61.4%, and superinfection rate is 32.4%, and triple infection rate is 6.5%.Rough estimation, China is used for the direct medical cost of hepatitis symptomatic treatment every year more than 100,000,000,000 yuans.Except first, second, The third, outside the hepatitis that hepatitis E virus is caused, at present it has been demonstrated that cytomegalovirus (CMV), simple Herpesvirus (HHV) etc. all can cause viral hepatitis.
Cytomegalovirus (CMV) is also known as cells inclusions virus, due to the cell enlargement infected, and has huge Intranuclear inclusion, therefore named.It is a kind of herpesvirus group DNA viruses.Widely distributed, other animals are all Can be infected, causing with urogenital system, central nervous system and liver disease is main each system sense Dye, from slight symptomless infection until major defect or death.
Cytomegalovirus Infection is that the congenital or posteriority caused by cytomegalovirus (CMV) infects, multilist It is now stealthy infection, clinic most commonly interstitial pneumonia, hepatitis, gastroenteritis, retinitis etc..
Summary of the invention
It is an object of the invention to provide a kind of prescription treating cytomegalovirus infectivity hepatitis.
To achieve these goals, the technical solution used in the present invention is:
A kind of prescription treating cytomegalovirus infectivity hepatitis, the weight proportion of its each raw material components is: wide Radix Curcumae 3, Chinese Magnoliavine 2, Radix Bupleuri 1, Fructus Forsythiae 1, Cortex Moutan 1, PINGDIMU 1, Rhizoma Paridis 1, Rhizoma Polygoni Cuspidati Root 1, Herba Lobeliae Chinensis 2, Herba Hedyotidis Diffusae 2, Rhizoma Atractylodis Macrocephalae (parched) 1, RHIZOMA ALISMATIS 1, Radix Pseudostellariae 2, decocting half an hour, Filtrate is administered orally;Potion, divided two to three times and was administered orally every day;Oral one to three month.
The prescription for the treatment of cytomegalovirus infectivity hepatitis provided by the present invention, its therapeutic effect is good, nontoxic Side effect.Cytomegalovirus belongs to the categories such as the vaginal bleeding during pregnancy of the traditional Chinese medical science, frequent fetal movement, induced abortion, habitual abortion, and it is sick Because mostly being congenital innate deficiency or losing the day after tomorrow foster, so that positive QI-insufficiency, and the place of defending does not infects evil poison admittedly, its Property heat, there is infectiousness.So-called " being gathered of heresy, its gas must be empty ", Chinese medicine thinks that the kidney being the origin of congenital constitution, Main reproduction, is the important internal organs promoting growth in humans to grow, sustain life and produce offspring.If the essence of parents Deficiency, tire does not become real, then affects nausea, and modern medicine is thought owing to gestation causes immunological function repression to promote The generation of cytomegalovirus infection and the activation of latent virus, so cause fetal in utero to infect, chorion And blood capillary skin is impaired, placental barrier destroys, and pathogen enters embryo.The traditional Chinese medical science is thought, the primary disease origin cause of formation is many Being caused hepatitis by retention of damp-heat in the interior, damp-heat blocking in the body in liver and gall and lose in thin profit, bile leaks, and overflows caused by skin.This Using soothing the liver blood stasis dispelling, eliminating damp-heat, heat-clearing and toxic substances removing in the side that invention provides, strengthening the body resistance, with the most strongly fragrant in side Gold, Radix Bupleuri, PINGDIMU, Rhizoma Paridis are with soothing the liver, blood stasis dispelling, polygoni cuspidati,radix, Herba Lobeliae Chinensis, Fructus Forsythiae, pellet Skin, RHIZOMA ALISMATIS, Herba Hedyotidis Diffusae are with heat clearing away, dampness removing, removing toxic substances, and Radix Pseudostellariae, Rhizoma Atractylodis Macrocephalae (parched), Chinese Magnoliavine are to hold up Just consolidate.All medicines share the curative effect reaching treating both the principal and the secondary aspects of a disease at the same time.
Detailed description of the invention
Below in conjunction with embodiment, the invention will be further described.
A kind of prescription treating cytomegalovirus infectivity hepatitis, the weight proportion of its each raw material components is: wide Radix Curcumae 3, Chinese Magnoliavine 2, Radix Bupleuri 1, Fructus Forsythiae 1, Cortex Moutan 1, PINGDIMU 1, Rhizoma Paridis 1, Rhizoma Polygoni Cuspidati Root 1, Herba Lobeliae Chinensis 2, Herba Hedyotidis Diffusae 2, Rhizoma Atractylodis Macrocephalae (parched) 1, RHIZOMA ALISMATIS 1, Radix Pseudostellariae 2.
Above-mentioned medical material was soaked in water after half an hour, then decocting half an hour, and filtrate is administered orally;Every day, potion, divided It is administered orally for two to three times;Oral one to three month is a course for the treatment of.
57 example patients are treated by clinic, the maleest 36 examples, female 21 example, the oldest 7 years old, minimum 10 months, after taking medicine three months, glutamate pyruvate transaminase (ACT), glutamic oxaloacetic transaminase, GOT (AST), total bilirubin were just Often, giant cell is turned out cloudy 54 examples, total cure rate 94.7%.ACT, AST, total bilirubin are normal, giant cell sun Property person 2 example, total effective rate 98.2%.

Claims (1)

1. treating a prescription for cytomegalovirus infectivity hepatitis, the weight proportion of its each raw material components is: RADIX CURCUMAE 3, Chinese Magnoliavine 2, Radix Bupleuri 1, Fructus Forsythiae 1, Cortex Moutan 1, PINGDIMU 1, Rhizoma Paridis 1, tiger Cane root 1, Herba Lobeliae Chinensis 2, Herba Hedyotidis Diffusae 2, Rhizoma Atractylodis Macrocephalae (parched) 1, RHIZOMA ALISMATIS 1, Radix Pseudostellariae 2, decocting half an hour, Filtrate is administered orally;Potion, divided two to three times and was administered orally every day;Oral one to three month.
CN201610255404.4A 2016-04-14 2016-04-14 Prescription for treating cytomegalovirus infectious heptitis Pending CN105853911A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201610255404.4A CN105853911A (en) 2016-04-14 2016-04-14 Prescription for treating cytomegalovirus infectious heptitis

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201610255404.4A CN105853911A (en) 2016-04-14 2016-04-14 Prescription for treating cytomegalovirus infectious heptitis

Publications (1)

Publication Number Publication Date
CN105853911A true CN105853911A (en) 2016-08-17

Family

ID=56632878

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201610255404.4A Pending CN105853911A (en) 2016-04-14 2016-04-14 Prescription for treating cytomegalovirus infectious heptitis

Country Status (1)

Country Link
CN (1) CN105853911A (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN115554248A (en) * 2022-08-25 2023-01-03 平阳润德医院有限公司 Enteric-coated traditional Chinese medicine preparation for treating infantile cytomegalovirus infectious hepatitis and preparation method thereof

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1460514A (en) * 2003-07-08 2003-12-10 中国人民解放军第三○二医院 Chinese medicine composite for curing chronic hepatitis B, fibrosis of liver and for curing SARS

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1460514A (en) * 2003-07-08 2003-12-10 中国人民解放军第三○二医院 Chinese medicine composite for curing chronic hepatitis B, fibrosis of liver and for curing SARS

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN115554248A (en) * 2022-08-25 2023-01-03 平阳润德医院有限公司 Enteric-coated traditional Chinese medicine preparation for treating infantile cytomegalovirus infectious hepatitis and preparation method thereof
CN115554248B (en) * 2022-08-25 2023-09-22 平阳润德医院有限公司 Enteric-coated traditional Chinese medicine preparation for treating infant cytomegalovirus infectious hepatitis and preparation method thereof

Similar Documents

Publication Publication Date Title
US6455078B1 (en) Medicinal herbal composition for treating liver diseases and HIV
CN110870402A (en) Prescription for treating pneumonia infected by novel coronavirus and application thereof
EP1386614A1 (en) Herbal pharmaceutical composition for treatment of hiv/aids patients
CN1329047C (en) Chinese medicinal composition for treating acute icterohepatitis
CN105853911A (en) Prescription for treating cytomegalovirus infectious heptitis
CN105288513A (en) Traditional Chinese medicine composition for treating hepatitis B and cirrhosis
CN101461857B (en) Medicament for treating severe hepatitis
CN106177156A (en) A kind of Chinese medicine composition preventing and treating infectious bovine rhinotrachetis and application thereof
CN111228388A (en) A pharmaceutical composition for treating hepatopathy, and its application method
CN103536851A (en) Traditional Chinese medicine composition for treating alcoholic fatty liver
CN113476542B (en) Application of composition in preparation of medicines and kits
CN103505500B (en) A kind of Chinese medicine composition for the treatment of hepatitis B and preparation method thereof
CN105940777B (en) A kind of antiviral Chinese medicine composition
CN102225185B (en) Traditional Chinese medicine composition for treating condyloma acuminatum and preparation method thereof
CN103191386B (en) Medicament for treating chronic hepatitis B
CN106492016A (en) A kind of compound Chinese medicinal preparation of anti-pig blue-ear disease and preparation method thereof
CN102370753A (en) Chinese herbal medicine decoction for treating herpes zoster
CN100409865C (en) Compound medicine for treating hepatitis B
Yan et al. Current state of clinical diagnosis and treatment of infantile cytomegaloviral hepatitis
CN104706741A (en) Traditional Chinese medicine for treating hepatitis
CN100335101C (en) Dysmenorrhea treating medicine
CN103585239B (en) A kind of preparation method of Boraginaceae extract and application thereof
CN104042873A (en) Chinese herbal mixture for treatment of syndrome of internally blocked epidemic toxin of fulminant dysentery
CN103585219B (en) The application of a kind of Altay Heteropappus hispidus (Thunb.) Less.-Aster hispidus Thunb. extract in preparation treatment AIDS-treating medicine
CN104069404A (en) Traditional Chinese medicine composition for treating oxyhepatitis or chronic hepatitis

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
RJ01 Rejection of invention patent application after publication

Application publication date: 20160817

RJ01 Rejection of invention patent application after publication